Conroy Kevin T's Form 4 filing
Exact Sciences Corp (EXAS) · filed Jul 6, 2022
- Accession no.
- 0001209191-22-041081
- Filed
- Jul 6, 2022
- Trade date
- May 2-Jul 1, 2022
- Filing delay
- 65 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $285.25. It was filed 65 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Conroy Kevin TCIK 0001306119 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 2, 2022 | Common Stock | AGrant or awardAcquired | +328 | $47.41 | +$15,550.48 | 1,167,934 | Direct | |
| Jul 1, 2022 | Common Stock | SSaleDisposed | −7 | $40.75 | −$285.25 | 1,167,927 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.